Ringberg A, Idvall I, Fernö M, Anderson H, Anagnostaki L, Boiesen P, Bondesson L, Holm E, Johansson S, Lindholm K, Ljungberg O, Ostberg G
Department of Plastic and Reconstructive Surgery, Malmö University Hospital, Sweden.
Eur J Surg Oncol. 2000 Aug;26(5):444-51. doi: 10.1053/ejso.1999.0919.
A standardized histopathological protocol has been designed, in which different histological characteristics of ductal carcinoma in situ (DCIS) are reported: nuclear grade (ng), growth pattern according to Andersen et al., necrosis, size of the lesion, resection margins and focality. Using this protocol a re-evaluation of a population-based consecutive series of 306 cases of DCIS has been done as well as a thorough clinical follow-up. After a median follow-up of 63 months, 13% have developed ipsilateral local recurrences, invasive and/or in situ. Ipsilateral local recurrence-free survival (IL-RFS) was significantly better for patients operated with mastectomy (ME) or breast conserving therapy (BCT) with radiotherapy (RT) than for patients operated with BCT without RT (5-year IL-RFS 96% vs 94% vs 79%, P<0.001). In the subgroup of BCT without RT there were significant differences in IL-RFS between histopathological subgroups: ng 1 + 2 (non-high grade) vs ng 3 (high grade; P=0.014), non-high-grade without comedo-type necrosis vs non-high-grade with comedo-type necrosis vs high-grade (the Van Nuys classification system; P=0.025). Growth pattern (not diffuse vs diffuse) and margins (free vs involved or not evaluated) showed a tendency (P=0.07 and 0.05, respectively) to be associated to IL-RFS. In contrast, no significant differences in IL-RFS were found in subgroups based on mode of detection, focality or size. Ninety-four per cent of the local recurrences after BCT appeared at the previous operation site.
In the BCT without RT group, combinations of either non-high grade and not a diffuse growth pattern or non-high grade and free margins identified groups (constituting approximately 30% of the patients) were at low risk of developing ipsilateral recurrences (6-10%), compared to a 31-37% recurrence risk in the remaining groups during the observed follow-up time. The beneficial effect of post-operative RT for these low-risk groups can be questioned, and should be studied further.
设计了一种标准化的组织病理学方案,用于报告导管原位癌(DCIS)的不同组织学特征:核分级(ng)、根据安德森等人的生长模式、坏死、病变大小、手术切缘和灶性。使用该方案对基于人群的连续306例DCIS病例进行了重新评估,并进行了全面的临床随访。中位随访63个月后,13%的患者出现同侧局部复发,包括浸润性和/或原位复发。接受乳房切除术(ME)或保乳治疗(BCT)并放疗(RT)的患者同侧局部无复发生存率(IL-RFS)显著优于接受BCT但未放疗的患者(5年IL-RFS分别为96%、94%和79%,P<0.001)。在未放疗的BCT亚组中,组织病理学亚组之间的IL-RFS存在显著差异:ng 1+2(非高级别)与ng 3(高级别;P=0.014),非高级别无粉刺样坏死与非高级别有粉刺样坏死与高级别(范努伊斯分类系统;P=0.025)。生长模式(非弥漫性与弥漫性)和切缘(阴性与阳性或未评估)显示出与IL-RFS相关的趋势(分别为P=0.07和0.05)。相比之下,基于检测方式、灶性或大小的亚组中,IL-RFS没有显著差异。BCT后94%的局部复发发生在先前的手术部位。
在未放疗的BCT组中,非高级别且非弥漫性生长模式或非高级别且切缘阴性的组合所确定的组(约占患者的30%)同侧复发风险较低(6-10%),而在观察到的随访期间,其余组的复发风险为31-37%。对于这些低风险组,术后放疗的有益效果值得质疑,应进一步研究。